KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $247,676,000 | +38.5% | 1,377,399 | -20.1% | 0.02% | +31.2% |
Q2 2017 | $178,785,000 | +51.6% | 1,724,567 | +14.8% | 0.02% | +45.5% |
Q1 2017 | $117,942,000 | +33.7% | 1,502,672 | -23.6% | 0.01% | +37.5% |
Q4 2016 | $88,217,000 | -0.3% | 1,967,213 | +24.2% | 0.01% | -11.1% |
Q3 2016 | $88,454,000 | +23.6% | 1,583,520 | +10.6% | 0.01% | +12.5% |
Q2 2016 | $71,557,000 | +17.0% | 1,431,129 | +7.4% | 0.01% | +14.3% |
Q1 2016 | $61,162,000 | -2.7% | 1,332,147 | +30.6% | 0.01% | 0.0% |
Q4 2015 | $62,831,000 | +24.7% | 1,019,666 | +12.7% | 0.01% | +16.7% |
Q3 2015 | $50,387,000 | -5.1% | 904,951 | +4.0% | 0.01% | 0.0% |
Q2 2015 | $53,069,000 | +82.8% | 870,492 | +73.0% | 0.01% | +100.0% |
Q1 2015 | $29,024,000 | +322.2% | 503,218 | +322.1% | 0.00% | +200.0% |
Q4 2014 | $6,874,000 | +234.5% | 119,208 | +65.3% | 0.00% | – |
Q3 2014 | $2,055,000 | – | 72,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |